The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Outpatient Treatment of Recent-Onset Atrial Fibrillation with the “Pill-in-the-Pocket” Approach
Open accessAbstract
BACKGROUND: In-hospital administration of flecainide and propafenone in a single oral loading dose has been shown to be effective and superior to placebo in terminating atrial fibrillation. We evaluated the feasibility and the safety of self-administered oral loading of flecainide and propafenone in terminating atrial fibrillation of recent onset outside the hospital. METHODS: We administered either flecainide or propafenone orally to restore sinus rhythm in 268 patients with mild heart disease or none who came to the emergency room with atrial fibrillation of recent onset that was hemodynamically well tolerated. Of these patients, 58 (22 percent) were excluded from the study because of treatment failure or side effects. Out-of-hospital self-administration of flecainide or propafenone--the "pill-in-the-pocket" approach--after the onset of heart palpitations was evaluated in the remaining 210 patients (mean age [+/-SD], 59+/-11 years). RESULTS: During a mean follow-up of 15+/-5 months, 165 patients (79 percent) had a total of 618 episodes of arrhythmia; of those episodes, 569 (92 percent) were treated 36+/-93 minutes after the onset of symptoms. Treatment was successful in 534 episodes (94 percent); the time to resolution of symptoms was 113+/-84 minutes. Among the 165 patients with recurrences, the drug was effective during all the arrhythmic episodes in 139 patients (84 percent). Adverse effects were reported during one or more arrhythmic episodes by 12 patients (7 percent), including atrial flutter at a rapid ventricular rate in 1 patient and noncardiac side effects in 11 patients. The numbers of monthly visits to the emergency room and hospitalizations were significantly lower during follow-up than during the year before the target episode (P<0.001 for both comparisons). CONCLUSIONS: In a selected, risk-stratified population of patients with recurrent atrial fibrillation, pill-in-the-pocket treatment is feasible and safe, with a high rate of compliance by patients, a low rate of adverse events, and a marked reduction in emergency room visits and hospital admissions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An alternative to emergency department treatment for patients with infrequent but disabling AF is the”
From 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry (2017) · cites this paper as Alboni et al., 2004
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.
Haïssaguerre, M., Jaïs, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., Garrigue, S., Mouroux, A. L., Métayer, P. L., & Clémenty, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809033391003 · Cited by 8,040
Models for Longitudinal Data: A Generalized Estimating Equation Approach
Zeger, S. L., Liang, K., & Albert, P. S. (1988) · Biometrics · doi:10.2307/2531734 · Cited by 4,505
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Gelder, I. C. V., Hagens, V. E., Bosker, H. A., Kingma, J. H., Otto Kamp, B., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,355
Hohnloser, S. H., Kück, K., & Lilienthal, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03230-x · Cited by 1,132
Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation
CARLSSON, J., Miketíc, S., Windeler, J., Cuneo, A., Haun, S., Micus, S., Walter, S., & Tebbe, U. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00332-2 · Cited by 938
Capucci, A., Lenzi, T., Boriani, G., Trisolino, G., Binetti, N., Cavazza, M., Fontana, G. A., & Magnani, B. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91392-h · Cited by 227
Capucci, A., Boriani, G., Botto, G. L., Lenzi, T., Rubino, I., Falcone, C., Trisolino, G., Casa, S. D., Binetti, N., Cavazza, M., et al. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90915-6 · Cited by 172
Self-citationBoriani, G., Biffi, M., Capucci, A., Botto, G. L., Broffoni, T., Rubino, I., Casa, S. D., Sanguinetti, M., & Magnani, B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-8-199704150-00006 · Cited by 171
Self-citationKhan, I. A. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01116-5 · Cited by 145
Flagged first, then by citations
Research works printed but not linked: 1
- Villani GQ, 1990, G Ital Cardiol, 20, 564
Cited by
Sorted by citations
Items 301–400 of 478
Tratamiento antiarrítmico farmacológico en fase crónica de la fibrilación auricular
Martí‐Almor, J., Bazán, V., Vallès, E., & Benito, B. (2013) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(13)70055-4 · Cited by 3
Propafenone‐Induced Syncope and Atrial Pacemaker
Wágner, V., Nényei, Z., & Tomcsányi, J. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12204 · Cited by 2
Evaluating the benefits of home-based management of atrial fibrillation: current perspectives
Sheikh, A. B., Felzer, J., Munir, A., Morin, D. P., & Lavie, C. J. (2016) · Pragmatic and Observational Research · doi:10.2147/por.s96670 · Cited by 2
“ED visits and hospitalizations were significantly lower than prior to the year prior.(116) Another study on 122 patients with”
Pill-in-the-Pocket for Paroxysmal Atrial Fibrillation: A Review and Case Study
Hussein, M. T. E., & Pamnani, P. (2024) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2024.105080 · Cited by 2
2025 Thai guideline for the diagnosis and management of atrial fibrillation
Ngarmukos, T., Methavigul, K., Rungpradubvong, V., Apiyasawat, S., Wongcharoen, W., Pumprueg, S., Boonyapisit, W., Suwanagool, A., Chantrarat, T., Makarawate, P., et al. (2025) · Asian Biomedicine · doi:10.2478/abm-2025-0028 · Cited by 2
“Furthermore, in patients with AF and HFrEF, if AF is thought to worsen HF symptoms (AF-aggravated HF), studies such as CASTLE-AF [91] and CASTLE-HTx [92] showed that catheter ablation to treat AF can significantly reduce mortality and hospitalization due to HF compared to medication.”
How to Manage Atrial Fibrillation in the Emergency Department: a Critical Appraisal
Magliari, R. T., & de Alencar, J. N. (2020) · Journal of Cardiac Arrhythmias · doi:10.24207/jca.v33i1.3390 · Cited by 3
Cardioversion in atrial fibrillation. Focus on recent-onset atrial fibrillation
Tampieri, A., Rusconi, A. M., & Lenzi, T. (2012) · Internal and Emergency Medicine · doi:10.1007/s11739-012-0863-0 · Cited by 2
“It consists in taking an oral loading dose of class IC drugs (flecainide or propafenone) as outpatients, resulting in a marked reduction in emergency room visits and hospital admission [41].”
BackgroundCatheter Ablation of Atrial Fibrillation Should Be Offered as Primary Therapy: What’s Your Hurry?
Wedam, E. F., & Haigney, M. C. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.05.020 · Cited by 2
Ablation should not be first-line therapy for the treatment of atrial fibrillation
Haigney, M. C. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.4.673 · Cited by 2
Atrial Fibrillation and Managed Care: Current Approaches and Future Directions for Long-Term Therapy
Sanoski, C. A., Kalus, J. S., & Johnson, S. G. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.s6-b.1 · Cited by 2
Diagnostic Evaluation and Follow-Up of Patients with Atrial Fibrillation
Dillon, P., & Ghanbari, H. (2016) · Heart Failure Clinics · doi:10.1016/j.hfc.2015.08.015 · Cited by 2
Leczenie farmakologiczne napadów migotania przedsionków
Jankiewicz-Błoch, A., Zawadzki, J. M., Kustrzycki, W., & Sławuta, A. (2018) · Folia Cardiologica · doi:10.5603/fc.2018.0071 · Cited by 2
D, H. W. D. M. (2014) · Europe PMC (PubMed Central) · doi:10.4022/jafib.978 · Cited by 2
Kirchhof, P. F., & BREITHARDT, G. E. (2007) · Der Internist · doi:10.1007/s00108-007-1899-5 · Cited by 2
Anti-arrhythmic Drugs—a Review and Comment on Relevance in the Current Era: Part 1
Hanayneh, S., Panna, M. E., Miles, W. M., & Goel, R. (2021) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-021-00940-3 · Cited by 2
“As mentioned above, it is recommended to co-administer AV nodal blocking agents such as beta blockers or non-dihydropyridine Ca channel blockers [5, 41].”
BackgroundAnti-arrhythmic drugs in atrial fibrillation: tailor-made treatments
Capucci, A., Stronati, G., & Guerra, F. (2023) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suad033 · Cited by 2
“If administered early (< 10 min after the symptoms started), 94% of patients reported the resolution of symptoms within 4 h, thus avoiding the need for medical consultation, and only 7% described (mostly mild) adverse events.(13) A ‘pill in the pocket’ approach could be also recommended to those patients with sporadic…”
BackgroundReview of Recent Trials of Medical Therapy for Atrial Fibrillation
Stuglin, C., & Wyse, D. G. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-163-5_11 · Cited by 2
Pharmacologic Conversion of Atrial Fibrillation and Atrial Flutter
Marinelli, A., & Capucci, A. (2010) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2010.06.002 · Cited by 2
Controversies in the “pill in the pocket” approach to atrial fibrillation
Riccardi, A., & Lerza, R. (2008) · Internal and Emergency Medicine · doi:10.1007/s11739-008-0108-4 · Cited by 2
“The ‘‘pill in the pocket’’ approach to paroxysmal AF has proven to be feasible and effective in obtaining rhythm control, but should be limited to carefully selected patients [ 6 , 7]. In the study by Alboni and colleagues, the selection criteria of patients were strict and severe, and in two of the main patient recru…”
BackgroundMethodInfluentialRationale und rationelle Behandlung des Vorhofflimmerns
Lüderitz, B. (2008) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-008-0043-y · Cited by 2
Camm, A. J., Kirchhof, P. F., Ernst, S., Gelder, I. C. V., Hindricks, G., Heidbüchel, H., Colonna, P., Goette, A., Hohloser, S. H., Kolh, P. H., et al. (2010) · Cited by 2
Hennersdorf, M., & Strauer, B. E. (2006) · Der Internist · doi:10.1007/s00108-006-1693-9 · Cited by 2
Hwang, Y. M., Lim, H. E., Lee, D. I., Yu, H. T., Park, Y. M., & Joung, B. (2021) · Korean Journal of Medicine · doi:10.3904/kjm.2021.96.4.264 · Cited by 1
Atrial Fibrillation: Rate Versus Rhythm Control
Vargas, C., Bhatnagar, M., Ahmed, H. S., Flynn, M. G., & Alexander, T. (2023) · HCA Healthcare Journal of Medicine · doi:10.36518/2689-0216.1564 · Cited by 1
Challenges and Opportunities for Atrial Fibrillation Management
Cai, M., & Heijman, J. (2025) · Cardiology Discovery · doi:10.1097/cd9.0000000000000155 · Cited by 1
“[140,142] However, after the Cardiac Arrhythmia Suppression Trial (CAST) showed increased mortality with class Ⅰ AADs in the setting of ischemia, these AADs have become contraindicated for patients with structural heart diseases, heart failure, and coronary artery disease.”
Diretriz Brasileira de Fibrilação Atrial – 2025
Cintra, F. D., Pisani, C. F., Rezende, A. G. D. S., Henz, B. D., Armaganijan, L., Pimentel, M., Lópes, R. D., do Nascimento, T. A., Lorga-Filho, A. M., de Albuquerque, A., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250618 · Cited by 21
Estándares SEA 2026 para el control global del riesgo vascular
Mostaza, J. M., Pintó, X., Armario, P., Guijarro, C., Masana, L., Real, J. T., Arrobas-Velilla, T., Baeza‐Trinidad, R., Calmarza, P., Cebollada, J., et al. (2026) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2025.500889 · Cited by 1
Cardioversion strategy in atrial fibrillation and atrial flutter (review)
Gagloeva, D. A., Станиславовна, К. Е., Mironov, N. Y., & Sp, G. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6708 · Cited by 2
Antiarrhythmic Drugs for Rhythm Control of Atrial Fibrillation: Unmet Needs and Future Directions
Campbell, K. B., Singh, J. P., & Zeitler, E. P. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.04.030 · Cited by 1
Therapeutisches Management des nichtvalvulären Vorhofflimmerns
Bode, K., Sommer, P., Bollmann, A., & Hindricks, G. (2013) · Herz · doi:10.1007/s00059-013-3940-x · Cited by 1
Atrial fibrillation guidelines for management: what's new?
Berry, E., Padgett, H., & Holton, C. (2015) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2015.10.9.426 · Cited by 1
The Place of Antiarrhythmic Drugs and Rhythm Control in the Treatment of Atrial Fibrillation
Chevalier, P., & Chief, C. E. (2009) · European Cardiology Review · doi:10.15420/ecr.2009.5.1.36 · Cited by 1
Rate versus rhythm control strategies for AF
Olshansky, B. (2005) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-005-0021-3 · Cited by 1
“The “pill-in-the-pocket” approach (intermittent drug use to stop AF) is advocated for patients with paroxysmal AF at low risk for a proarrhythmic event [ 37 ].”
BackgroundAizawa, Y. (2010) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s12491 · Cited by 1
Catheter ablation for paroxysmal atrial fibrillation
Richards, G. (2012) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2012.7.11.518 · Cited by 1
Pharmacologic targets for atrial fibrillation
Bhakta, D., & Miller, J. M. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.9.1161 · Cited by 1
Gillis, A. M., Verma, A., Talajic, M. R., Nattel, S., & Dorian, P. (2011) · Cited by 1
Atrial fibrillation: state of the art
Hasun, M., Gatterer, E., & Weidinger, F. F. (2014) · Wiener klinische Wochenschrift · doi:10.1007/s00508-014-0667-5 · Cited by 1
Management des Vorhofflimmerns
Hilbert, S., Bode, K., John, S., Kircher, S., Müssigbrodt, A., Dagres, N., & Hindricks, G. (2014) · Der Kardiologe · doi:10.1007/s12181-014-0613-9 · Cited by 1
Glover, B. M., & Dorian, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-40818-7_10 · Cited by 1
Tratamiento farmacológico de la fibrilación auricular. Antiarrítmicos y anticoagulantes orales
Cosı́n-Sales, J., & Olalla, J. J. (2016) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(16)30012-7 · Cited by 3
Lardizabal, J. A., & Sharma, S. (2013) · Journal of Hypertension and Cardiology · doi:10.14302/issn.2329-9487.jhc-12-edt1 · Cited by 1
“The strategy involves self - administering single oral dose of either flecainide (200 – 300 mg) or propafenone (450 – 600 mg) upon onset of symptomatic palpitations ( 36 ) .”
Fernández, A. B., Crespo, E. M., & Thompson, P. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00065-1 · Cited by 1
Atrial fibrillation: current concepts.
Chutani, S. K., Imran, N., & Kanjwal, Y. (2008) · Europe PMC (PubMed Central) · Cited by 1
ZIMETBAUM, P. J., & Falk, R. H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0101-8.00020-5 · Cited by 1
Electrophysiological Changes of the Atrium in Patients with Lone Paroxysmal Atrial Fibrillation.
Murdock, D. K., Reiffel, J. A., Kaliebe, J., & Larrain, G. (2010) · Europe PMC (PubMed Central) · doi:10.4022/jafib.251 · Cited by 1
Pollet, M., & Saeed, M. (2016) · Texas Heart Institute Journal · doi:10.14503/thij-16-6088 · Cited by 1
Kuppuswamy, S., & Flaker, G. C. (2006) · CRC Press eBooks · doi:10.1201/b14679-7 · Cited by 1
SEA 2022 standards for the comprehensive control of cardiovascular risk
Mostaza, J. M., Pintó, X., Armario, P., Masana, L., Real, J. T., Valdivielso, P., Arrobas-Velilla, T., Baeza‐Trinidad, R., Calmarza, P., Cebollada, J., et al. (2022) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2022.06.002 · Cited by 1
Manejo da Fibrilação Atrial na Sala de Emergência
do Nascimento, T. A., Alves, N. M., & Lyra, M. G. (2022) · Revista Científica Hospital Santa Izabel · doi:10.35753/rchsi.v6i3.330 · Cited by 1
Antiarrhythmic drugs for atrial fibrillation in the outpatient setting
Tseng, A. S., DeSimone, C. V., & Kowlgi, G. N. (2023) · Minerva Medica · doi:10.23736/s0026-4806.23.08524-5 · Cited by 1
Reassessing the Safety of Pill-in-the-Pocket Propafenone
Kim, A. G., Yavari, M., Sabanci, R., Ukponmwan, E. U., & Ali‐Ahmed, F. (2023) · Cureus · doi:10.7759/cureus.46282 · Cited by 1
“This is important because the termination of atrial fibrillation can sometimes lead to bradycardia caused by sinus node or AV node dysfunction, or it can trigger a proarrhythmic response [4].”
BackgroundPropafenone Induced Takotsubo Cardiomyopathy: A Mere Coincidence or A New Causal Relationship?
Çakan, F., & Adar, A. (2023) · Düzce Tıp Fakültesi Dergisi · doi:10.18678/dtfd.1307722 · Cited by 1
Cardoso, A. F., Martins, L. C., Rocha, C. A. D. S., Pichara, N. L., Nikus, K. C., & Pérez‐Riera, A. R. (2025) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2025.154031 · Cited by 1
FIBRILACIÓN AURICULAR: MANEJO POR UNIDADES MÓVILES DE EMERGENCIAS
Pardillos-Ferrer, L., Rodríguez, A. J. B., & Marcos, C. C. (2009) · Prehospital Emergency Care (Edición Española) · Cited by 1
Le, V. T., & Muhlestein, J. B. (2018) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-018-0588-3 · Cited by 1
Prophylactic Antiarrhythmic Drug Therapy in Atrial Fibrillation.
Rodríguez‐Mañero, M., Sarkozy, A., Chierchia, G. B., Casado-Arroyo, R., Ricciardi, D., de Asmundis, C., Carlo de, A., & Sarkozy, P. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.636 · Cited by 1
Endurance Exercise and Atrial Fibrillation
Sareban, M., Guasch, E., & Mont, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-35374-2_33 · Cited by 1
Alsunbuli, A. (2020) · Clinical Medicine · doi:10.7861/clinmed.20-2-s4 · Cited by 1
Cardioversión eléctrica y cardioversión farmacológica en pacientes con fibrilación auricular
Ayaviri, D. E., Arnez, S. O., Gutiérrez, J. A., Gil, A. S. S., & Aguilar, M. L. O. (2020) · Revista Científica de Salud UNITEPC · doi:10.36716/unitepc.v7i1.67
Cui, C., Li, Z., Ju, W., Yang, G., Gu, K., Liu, H., Li, M., Chen, H., Wang, J., & Chen, M. (2022) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14598 · Cited by 1
Adukauskaitė, A., & Stuehlinger, M. (2022) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-022-00913-4 · Cited by 2
Pharmakologische Therapie bei Vorhofflimmern – Was leisten moderne Antiarrhythmika wirklich?
Volkmann, H., Richter, L., & Bergmann, C. (2008) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-008-0034-z · Cited by 1
Atrial Fibrillation: Rhythm and Rate Control Therapies
Savelieva, I., Waldo, A. L., & Camm, A. J. (2009) · Wiley eBooks · doi:10.1002/9781444309768.ch35 · Cited by 1
Nair, M., Patra, S., & Aror, V. (2011) · InTech eBooks · doi:10.5772/22371 · Cited by 1
KHAN, M. G. (2006) · Elsevier eBooks · doi:10.1016/b978-012406061-6/50024-2 · Cited by 1
SCHRICKEL, J. W., Beiert, T., & Andrié, R. (2021) · Elsevier eBooks · doi:10.1016/b978-3-437-23834-5.00013-x · Cited by 1
Atrial Fibrillation in the Emergency Department: More Than “Meet ‘Em, Treat ‘Em, and Street ‘Em”
Andrade, J. G., & Macle, L. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.02.003 · Cited by 1
Atrial Fibrillation: Non Surgical Management
Khoo, C. W., & Lip, G. Y. H. (2010) · Springer eBooks · doi:10.1007/978-1-84996-426-5_13
Alboni, P. (2006) · Springer eBooks · doi:10.1007/88-470-0371-7_11
“Division of Cardiology and Arrhythmologic Centre, Ospedale Civile, Cento (Ferrara), Italy approach has been investigated in an Italian multi-centre study [ 17 ].”
BackgroundSelf-citationTaquicardia de QRS ancho tras la administración de adenosina
Moliner, J. V., González, J. J. S., Abadía, A. A., Valverde, A. G., Lacueva, M. I. M., & Peralta, L. J. P. (2008) · Dialnet (Universidad de la Rioja)
Rationelle Therapie von Vorhofflimmern in der Intensivmedizin
Hoffmann, B. A., Wilke, I., Drewitz, I., Steven, D., Rostock, T., & Willems, S. (2009) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-009-0056-x
Active Supraventricular Arrhythmias
de Luna, A. B. (2011) · Wiley eBooks · doi:10.1002/9781444391749.ch4
Rienstra, M., Wiesfeld, A. C. P., van Veldhuisen, D. J., & Gelder, I. C. V. (2006) · PubMed
Giniger, A. G. (2026) · Revista Argentina de Cardiología · doi:10.7775/rac.v75i4.2586
Estrategia para el control de ritmo de la fibrilación auricular en el escenario prehospitalario
Bazzino, O. O., & Mañana, P. (2010) · Redalyc (Universidad Autónoma del Estado de México)
KHAN, M. G. (2006) · Elsevier eBooks · doi:10.1016/b978-012406061-6/50018-7
Fumagalli, S., Boni, S., Gabbai, D., Giannini, I., Tarantini, F., & Marchionni, N. (2015) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0439-8
Cardioversión eléctrica y farmacológica de la fibrilación auricular
Kim, S. S., & Knight, B. P. (2008) · Clínicas médicas de Norteamérica
Zelfmedicatie bij aanvallen van onlangs ontstane atriumfibrillatie
van der Does, E. (2005) · Medisch-Farmaceutische Mededelingen · doi:10.1007/bf03058563
Wyse, D. G. (2005) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0124
Contrôle du rythme sinusal – Cardioversion
Bovéda, S., Marijon, É., Deplagne, A., Hausman, P., Bayomi, M. E., Combes, S., Combes, N., Bortone, A. A., & albenque, J. P. (2009) · Annales de Cardiologie et d Angéiologie · doi:10.1016/s0003-3928(09)73398-0
Aktuelle Therapiestrategien bei Vorhofflimmern
Drewitz, I., Rostock, T., Hoffmann, B. A., Steven, D., Servatius, H., Meinertz, T., Willems, S., & (AFNET)*, U. M. D. K. V. (2008) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-008-1123-y
Vorhofflimmern – alte und neue Prinzipien der pharmakologischen Rhythmusskontrolle
Lüderitz, B. (2007) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-007-0012-x
Medikamentöse Therapie von Herzrhythmusstörungen
Koller, M. L., & Schumacher, B. (2010) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-010-1004-z
A Novel Method of Fetal Cardioversion
Sanghavi, D. M. (2012) · Pediatric Cardiology · doi:10.1007/s00246-012-0316-6
Manejo de la fibrilaci?n/flutter auricular de reciente comienzo
Peafiel, P., Alberola, A. G., & Chvarri, M. V. (2008) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(08)75426-2
Pharmacologic Management of Atrial Fibrillation and Flutter
Saluja, D. S., Hickey, K. T., & Reiffel, J. A. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-161-5_8
Too Little, Too Late: Chasing Atrial Fibrillation with Sodium Channel Antagonists
Anderson, M. E. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00486.x
Medikamentöse Therapie des Vorhofflimmerns in speziellen Situationen
Pfeiffer, D., Jurisch, D., Kluge, J.-G., Hagendorff, A., & Klein, N. (2014) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-014-0301-2
“Eine Pill-inthe-pocket-Strategie beim Holiday-heartSyndrom bietet sich an [2].”
BackgroundSimethicone—another “pill in the pocket” in paroxysmal atrial fibrillation?
Litmathe, J., & Litmathe, A. M. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.11.057
‘Pill-in-the-pocket’ treatment for recent-onset atrial fibrillation
Alboni, P., Botto, G. L., Boriani, G., Russo, G., Pacchioni, F., Iori, M., Pasanisi, G., Mancini, M., Maricanti, B., & Cappucci, A. (2010) · Heart · doi:10.1136/hrt.2010.202994
“regarding ‘pill-in-the-pocket’ treatment of recent-onset atrial fibrillation (AF). Only 122 patients with AF were enrolled following successful in-hospital treatment with intravenous flecainide or propafenone because the study was interrupted on the recommendation of the data and safety monitoring committee. In this r…”
Self-citationManejo general y extrahospitalario del paciente con taquiarritmias
Rubio, D. M., del Pino, C. L., Sánchez, M. A., & Ortega, M. D. (2009) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(09)72007-4
Rhythm control strategies for symptomatic atrial fibrillation
Hemels, M. E. W. (2007) · University of Groningen research database (University of Groningen / Centre for Information Technology)
2009 Lifelong Learning And Self-Assessment Study Guide
Williford, R., Alvarez, L., & Pai, J. (2009)
Rate and Rhythm Control Strategies for Atrial Fibrillation
Yap, Y. G., & Camm, A. J. (2014) · doi:10.1007/978-1-907673-98-6_4
Imaging of the Pulmonary Veins in Patients with Atrial Fibrillation
Poon, M., & Learra, C. (2006) · Springer eBooks · doi:10.1007/978-3-540-49546-8_19
Antiarrhythmic therapy in patients with atrial fibrillation
Wysocka, A., Karaś-Głodek, M., & Wysokiński, A. P. (2015) · Postępy Nauk Medycznych
Zhen-dong, S. H. I., & Ma, Y. (2014) · 国际临床报告 · doi:10.14725/gjcr.v1n3a610
Metadata
- Authors
- Alboni, P., Botto, G. L., Baldi, N., Luzi, M., Russo, V., Gianfranchi, L., Marchi, P., Calzolari, M., Solano, A., Baroffio, R., & Gaggioli, G.
- Affiliations
- Ospedale Sant'Anna (IT)
- Ospedale SS. Annunziata (IT)
- Santa Maria Nuova Hospital (IT)
- ORCID
- Botto, Giovanni L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-12-02
- Volume
- 351
- Issue
- 23
- Pages
- 2384-2391
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2026137049
- Cited by
- 479
- References
- 28
- Citations by year
- 2026: 15 · 2025: 11 · 2024: 18 · 2023: 19 · 2022: 16 · 2021: 21 · 2020: 21 · 2019: 10 · 2018: 18 · 2017: 22 · 2016: 25 · 2015: 20 · 2014: 31 · 2013: 23 · 2012: 20
- FWCI
- 16.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- atrial fibrillation, flecainide, propafenone, oral loading dose, outpatient care, self-administration, sinus rhythm restoration, emergency department visits, hospitalization reduction, adverse drug reactions, atrial flutter
- MeSH terms
- Administration, Oral, Ambulatory Care, Anti-Arrhythmia Agents, Atrial Fibrillation, Feasibility Studies, Female, Flecainide, Follow-Up Studies, Heart Failure, Humans, Male, Middle Aged, Propafenone, Prospective Studies, Self Administration, Stroke Volume
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
